These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 18622917)

  • 1. [Genetic counseling in familial breast cancer].
    Pichert G
    Ther Umsch; 2008 Apr; 65(4):235-41. PubMed ID: 18622917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Risk assessment for familial occurrence of breast cancer].
    Chang-Claude J; Becher H; Hamann U; Schroeder-Kurth T
    Zentralbl Gynakol; 1995; 117(8):423-34. PubMed ID: 7571905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hereditary predisposition for cancer of the breast and the ovary].
    Lalle P; Stoppa-Lyonnet D; Mazoyer S; Rio P; Girodet C; Hardouin A; Narod SA; Sobol H; Bignon YJ
    Bull Cancer; 1993 Oct; 80(10):857-65. PubMed ID: 8204923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRCA1 gene testing for breast and ovarian cancer in one family.
    Crosbie A; Brewer C; Campbell K; MacKay J
    Br J Nurs; 1998 Dec 10-1999 Jan 13; 7(22):1386-92. PubMed ID: 10076219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The importance of genetic factors for development of breast cancer].
    Chang-Claude J; Eby N; Becher H
    Zentralbl Gynakol; 1994; 116(12):660-9. PubMed ID: 7846977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial ovarian carcinoma: a problem in genetic counselling.
    Nevo S
    Clin Genet; 1978 Oct; 14(4):219-22. PubMed ID: 699361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hereditary breast-ovarian cancer: clinical findings and medical management.
    Marshall M; Solomon S
    Plast Surg Nurs; 2007; 27(3):124-7. PubMed ID: 17901820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA screening for breast/ovarian cancer susceptibility based on linked markers. A family study.
    Lynch HT; Watson P; Conway TA; Lynch JF; Slominski-Caster SM; Narod SA; Feunteun J; Lenoir G
    Arch Intern Med; 1993 Sep; 153(17):1979-87. PubMed ID: 8357282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic counselling and testing for susceptibility to breast, ovarian and colon cancer: where are we today?
    Cole DE; Gallinger S; McCready DR; Rosen B; Engel J; Malkin D
    CMAJ; 1996 Jan; 154(2):149-55. PubMed ID: 8548703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age.
    van der Kolk DM; de Bock GH; Leegte BK; Schaapveld M; Mourits MJ; de Vries J; van der Hout AH; Oosterwijk JC
    Breast Cancer Res Treat; 2010 Dec; 124(3):643-51. PubMed ID: 20204502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline BRCA1-2 mutations in non-Ashkenazi families with double primary breast and ovarian cancer.
    Schorge JO; Mahoney NM; Miller DS; Coleman RL; Muller CY; Euhus DM; Tomlinson GE
    Gynecol Oncol; 2001 Nov; 83(2):383-7. PubMed ID: 11606101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer.
    Couch FJ; DeShano ML; Blackwood MA; Calzone K; Stopfer J; Campeau L; Ganguly A; Rebbeck T; Weber BL
    N Engl J Med; 1997 May; 336(20):1409-15. PubMed ID: 9145677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinics for counseling on cancer genetics. Experiences with genetic studies and counseling on familial breast cancer and colorectal cancer].
    Gerdes AM; Rasmussen K; Graversen HP; Kronborg O; Qvist N; Holm NV; Axelsson CK; Rose C; Ahrons S; Dyreborg U; Hørder M
    Ugeskr Laeger; 1998 Feb; 160(8):1145-51. PubMed ID: 9492624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary and familial ovarian cancer in southern Ontario.
    Narod SA; Madlensky L; Bradley L; Cole D; Tonin P; Rosen B; Risch HA
    Cancer; 1994 Oct; 74(8):2341-6. PubMed ID: 7922985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families.
    Antoniou AC; Durocher F; Smith P; Simard J; Easton DF;
    Breast Cancer Res; 2006; 8(1):R3. PubMed ID: 16417652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous interdisciplinary counseling in German breast/ovarian cancer families: first experiences with patient perceptions, surveillance behavior and acceptance of genetic testing.
    Hofferbert S; Worringen U; Backe J; Rückert EM; White K; Faller H; Grimm T; Caffier H; Chang-Claude J; Weber BH
    Genet Couns; 2000; 11(2):127-46. PubMed ID: 10893664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer risks for Australian women with a BRCA1 or a BRCA2 mutation.
    Suthers GK
    ANZ J Surg; 2007 May; 77(5):314-9. PubMed ID: 17497966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial breast cancer risk assessment.
    Johnson VP; Storm CA; Skorey-Solberg P; McHale MS
    S D J Med; 1996 Jul; 49(7):217-21. PubMed ID: 8755457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic epidemiology of breast cancer and associated cancers in high-risk families. I. Segregation analysis.
    Go RC; King MC; Bailey-Wilson J; Elston RC; Lynch HT
    J Natl Cancer Inst; 1983 Sep; 71(3):455-61. PubMed ID: 6577220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.